Could a cannabis-based mouth spray treat deadly brain tumours? Study

1 min read


About 2,200 people in England are diagnosed every year with the disease, making it the most common type of primary malignant brain tumour in adults.

The condition can form at any age, but tends to occur more often in older adults.

According to the Mayo Clinic, symptoms of the condition include headache, nausea, vomiting and seizures.

Susan Short, professor of clinical oncology and neuro-oncology at Leeds University, who is the principal investigator of the study, said: “We think that Sativex may kill glioblastoma tumour cells and that it may be particularly effective when given with temozolomide chemotherapy.



Leave a Reply

Your email address will not be published.

Previous Story

Harris’ border role faces new scrutiny after report of likely historic surge in unaccompanied children

Next Story

Pfizer Covid vaccine: The side effect 'more common' after second dose – CDC finding

Latest from Blog

withemes on instagram